2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies
2-Phenoxyacetamide group has been identified as one of markers in the discovery and development of SARS-CoV-2 antiviral agent through its main protease (Mpro) inhibition pathway. This study aims to study a series of 2-phenoxyacetamide derivatives using in silico method toward SARS-CoV-2 Mpro as the...
Main Authors: | Pandu Hariyono, Rini Dwiastuti, Muhammad Yusuf, Nurul H. Salin, Maywan Hariono |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Results in Chemistry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211715621001685 |
Similar Items
-
In silico prediction of the inhibitory effect of phytochemical components extracted from Knautia sarajevensis on the main protease of SARS-CoV-2 virus
by: Tarik Corbo, et al.
Published: (2022-12-01) -
Olive-Derived Triterpenes Suppress SARS COV-2 Main Protease: A Promising Scaffold for Future Therapeutics
by: Hani A. Alhadrami, et al.
Published: (2021-05-01) -
Cathepsin inhibitors as potent inhibitors against SARS-CoV-2 main protease. In silico molecular screening and toxicity prediction
by: O. Sekiou, et al.
Published: (2023-02-01) -
Mechanistic Insights into the Inhibition of SARS-CoV-2 Main Protease by Clovamide and Its Derivatives: In Silico Studies
by: Naike Ye, et al.
Published: (2021-09-01) -
In silico Screening of Potential SARS-CoV-2 Main Protease Inhibitors from Thymus schimperi
by: Mengist HM, et al.
Published: (2023-01-01)